1p/19q codeletion and RET rearrangements in small-cell lung cancer
The prognosis of small-cell lung cancer (SCLC) is poor despite reports suggesting modest improvement in survival. To date, chemotherapy remains the cornerstone treatment for SCLC patients, and many studies have focused on identifying the molecular characteristics of SCLC, which serve as the basis fo...
Main Authors: | Lu, Hongyang, Xu, Haimiao, Xie, Fajun, Qin, Jing, Han, Na, Fan, Yun, Mao, Weimin |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913998/ |
Similar Items
-
Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
by: Leomar Y. Ballester, et al.
Published: (2018-08-01) -
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
by: Leeper, Heather E., et al.
Published: (2015) -
A “Weighted” Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors
by: Senetta, Rebecca, et al.
Published: (2013) -
RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer
by: Sasaki, Hidefumi, et al.
Published: (2012) -
On the RET Rearrangements in Chernobyl-Related Thyroid Cancer
by: Jargin, Sergei V.
Published: (2012)